Literature DB >> 8821316

The prevalence, associations and symptoms of depression amongst dementia sufferers.

C Ballard1, C Bannister, M Solis, F Oyebode, G Wilcock.   

Abstract

OBJECTIVE: To examine the prevalence rates of RDC major and RDC minor depression in dementia sufferers, to compare the prevalence rates and symptoms of depression between different dementias and to look at the associations of RDC major depression.
DESIGN: Case control.
SETTING: Referrals to clinical services.
SUBJECTS: 124 patients with DSM-III-R dementia. MEASURES: The patients were assessed using the GMS/HAS package and the Cornell Depression Scale. Depression was diagnosed according to RDC criteria.
RESULTS: 25.0% of patients had RDC major depression and 27.4% had RDC minor depression. Major depression occurred significantly more often and was significantly more severe in patients with vascular dementia than patients with Alzheimer's disease. Severe visual impairment was significantly associated with RDC major depression in Alzheimer's disease and physical health problems were significantly associated with depression in vascular dementia. Most symptoms of depression including suicidal thoughts were common.
CONCLUSIONS: Major depression is more common and more severe in patients with vascular dementia. The associations of depression may be different in these patients.

Entities:  

Mesh:

Year:  1996        PMID: 8821316     DOI: 10.1016/0165-0327(95)00072-0

Source DB:  PubMed          Journal:  J Affect Disord        ISSN: 0165-0327            Impact factor:   4.839


  21 in total

Review 1.  Neuropsychiatric aspects of Alzheimer's disease.

Authors:  C Ballard; M Walker
Journal:  Curr Psychiatry Rep       Date:  1999-10       Impact factor: 5.285

2.  Incidence and predictive factors of depressive symptoms in Alzheimer's disease: the REAL.FR study.

Authors:  C Arbus; V Gardette; C E Cantet; S Andrieu; F Nourhashémi; L Schmitt; B Vellas
Journal:  J Nutr Health Aging       Date:  2011-08       Impact factor: 4.075

3.  Latent Classes of Cognitive Functioning Among Depressed Older Adults Without Dementia.

Authors:  Ruth T Morin; Philip Insel; Craig Nelson; Meryl Butters; David Bickford; Susan Landau; Andrew Saykin; Michael Weiner; R Scott Mackin
Journal:  J Int Neuropsychol Soc       Date:  2019-06-24       Impact factor: 2.892

Review 4.  Alzheimer's disease and mild cognitive impairment.

Authors:  Brendan J Kelley; Ronald C Petersen
Journal:  Neurol Clin       Date:  2007-08       Impact factor: 3.806

5.  Prevalence of Depression, Anxiety and PTSD in People with Dementia: a Systematic Review and Meta-Analysis.

Authors:  J K Kuring; J L Mathias; L Ward
Journal:  Neuropsychol Rev       Date:  2018-12-07       Impact factor: 7.444

6.  Dementia-specific assisted living: clinical factors and psychotropic medication use.

Authors:  Marianne Smith; Kathleen C Buckwalter; Hyunwook Kang; Vicki Ellingrod; Susan K Schultz
Journal:  J Am Psychiatr Nurses Assoc       Date:  2008-03       Impact factor: 2.385

Review 7.  Depression associated with dementia.

Authors:  H Gutzmann; A Qazi
Journal:  Z Gerontol Geriatr       Date:  2015-05-12       Impact factor: 1.281

8.  Vascular factors and risk for neuropsychiatric symptoms in Alzheimer's disease: the Cache County Study.

Authors:  Katherine A Treiber; Constantine G Lyketsos; Chris Corcoran; Martin Steinberg; Maria Norton; Robert C Green; Peter Rabins; David M Stein; Kathleen A Welsh-Bohmer; John C S Breitner; JoAnn T Tschanz
Journal:  Int Psychogeriatr       Date:  2008-02-21       Impact factor: 3.878

9.  The emerging modern face of mood disorders: a didactic editorial with a detailed presentation of data and definitions.

Authors:  Konstantinos N Fountoulakis
Journal:  Ann Gen Psychiatry       Date:  2010-04-12       Impact factor: 3.455

10.  Frontal lobe hypoperfusion and depressive symptoms in Alzheimer disease.

Authors:  Naama Levy-Cooperman; Amer M Burhan; Shahryar Rafi-Tari; Maggie Kusano; Joel Ramirez; Curtis Caldwell; Sandra E Black
Journal:  J Psychiatry Neurosci       Date:  2008-05       Impact factor: 6.186

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.